ACE2 is prominently expressed in the heart and plays a crucial role in counterbalancing the effects of angiotensin II, especially in conditions marked by excessive activation of the renin-angiotensin system, such as hypertension (HTN), congestive heart failure (CHF), and atherosclerosis (Clerkin et al., 2020). This evidence concerns the gene REN and congestive heart failure.